Back to company

PHARMAORIGIN ApS: Financial statements 2016

CVR: 29178291

PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -1,713,000 compared with DKK -135,000 the year before. Equity amounted to DKK 5,432,000. The solvency ratio was 100%.

Profit/Loss
-1,713,000 kr.
Equity
5,432,000 kr.
Total Assets
5,432,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016---1.7 mio.5.4 mio.-
2015---135 t.4.2 mio.-
2014---558 t.4.3 mio.-
201300-938 t.-132 t.-
2012---149 t.806 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAORIGIN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

Robert Norman Neville joins PHARMAORIGIN ApS as directorJul 15, 2016

As of July 15, 2016, Robert Norman Neville is registered as director of PHARMAORIGIN ApS.

Kim Arvid Nielsen steps down as adm. dir. of PHARMAORIGIN ApSJul 15, 2016

As of July 15, 2016, Kim Arvid Nielsen has stepped down as adm. dir. of PHARMAORIGIN ApS.

Savara ApS registered as owner of PHARMAORIGIN ApSJul 15, 2016

As of July 15, 2016, Savara ApS is registered as an owner of PHARMAORIGIN ApS with an ownership share of 100%.

PHARMAORIGIN ApS: The 2015 annual report is outJun 6, 2016

PHARMAORIGIN ApS has published its annual report for 2015. The net result was DKK -135,000.

Søren Bech Justesen steps down as director of PHARMAORIGIN ApSJan 22, 2016

As of January 22, 2016, Søren Bech Justesen has stepped down as director of PHARMAORIGIN ApS.

About PHARMAORIGIN ApS

PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity amounted to DKK 1,477,000.